staloral 300 ir/ml podjezično pršilo, raztopina
stallergenes - alergenski izvlečki - podjezično pršilo, raztopina - alergenski izvlečki 300 ir / 1 ml - razni alergenski ekstrakti
staloral 100 ir/ml ali 100 ic/ml podjezično pršilo, raztopina
stallergenes - alergenski izvlečki - podjezično pršilo, raztopina - alergenski izvlečki 100 ir / 1 ml - razni alergenski ekstrakti
curosurf 80 mg/ml suspenzija za endotraheopulmonalno vkapavanje
chiesi pharmaceuticals gmbh - poraktant alfa - suspenzija za endotraheopulmonalno vkapavanje - poraktant alfa 80 mg / 1 ml - naravni fosfolipidi
torecan 6,5 mg/ml raztopina za injiciranje
krka, d.d., novo mesto - tietilperazin - raztopina za injiciranje - tietilperazin 6,5 mg / 1 ml - tietilperazin
giotrif
boehringer ingelheim international gmbh - afatinib - karcinom, pljučni pljuč - antineoplastična sredstva - giotrif kot monotherapy je primerna za zdravljenje ofepidermal rastni dejavnik receptorjev (egfr) tki-naivna odraslih bolnikov z lokalno napredno ali metastatskim non-small cell lung cancer (nsclc) z aktiviranjem egfr mutacija(s);lokalno napredno ali metastatskim nsclc od skvamoznih histologijo napreduje na ali po platinum, ki temelji kemoterapijo.
pixuvri
les laboratoires servier - pixantrone dimaleate - limfom, non-hodgkin - antineoplastična sredstva - zdravilo pixuvri je indicirano kot monoterapija za zdravljenje odraslih bolnikov z multiplo relapsnimi ali neodzivnimi agresivnimi limfomi brez hodgkinov b celic (nhl). prednost piksantona pri bolnikih, ki se uporabljajo kot pete ali večje kemoterapije pri bolnikih, ki so odporni na zadnjo terapijo.
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
cytopoint
zoetis belgium sa - lokivetmab - drugi dermatološki preparati, sredstva za dermatitis, razen kortikosteroidi - psi - zdravljenje kliničnih manifestacij atopičnega dermatitisa pri psih.
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
epoprostenol lek 0,5 mg prašek in vehikel za raztopino za infundiranje
lek d.d. - epoprostenol - prašek in vehikel za raztopino za infundiranje - epoprostenol 0,5 mg / 1 viala - epoprostenol